The Effect of Exercise-Induced Irisin on Brain Function and Postoperative Delirium in Older Adults

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorPeking University People's Hospital

About this trial

The goal of this observational study is to learn how exercise-induced irisin protects the brain. It also explores irisin's effect on postoperative delirium (POD) in older adults. The main questions it aims to answer are:

Does daily activity link to POD? Does irisin play a mediating role in this process? Researchers will enroll active and inactive adults aged 65 and older. All will have surgery under spinal anesthesia. The researchers will measure irisin levels in spinal fluid. They will track POD and other complications for five days after surgery.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged ≥ 65 years;

Classified as ASA physical status I to III;

Scheduled for non-cardiovascular surgery under spinal anesthesia or combined spinal-epidural anesthesia;

Expected surgical duration of at least 2 hours;

Disqualifiers

Significant change in exercise status within the past 7 days due to injury or other reasons;

Contraindications to neuraxial anesthesia;

Unable to assess cognitive function or Montreal Cognitive Assessment (MoCA) score < 23;

Preoperative diagnosis of delirium;

Trial population

Patients scheduled for elective surgery at Peking University People's Hospital.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Preoperative physical activity level

    Behavioral

    Before the surgery, the activity levels of the participants over the past week were assessed using the Physical Activity Scale for the Elderly (PASE).

Treatment groups

140 Participants
are divided into 2 treatment groups
Group A: Insufficient Daily Exercise1 intervention
Group B: Regular Daily Exercise1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Delirium

Delirium will be assessed using the CAM or CAM-ICU (for patients in the ICU) by researchers twice daily. For patients who develop POD, the severity of POD will be evaluated using the Delirium Rating Scale-Revised-98 (DRS-R-98).

Time frame
five days after surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.